Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000734272 | SCV000862398 | uncertain significance | not provided | 2018-07-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001042782 | SCV001206485 | uncertain significance | Cohen syndrome | 2022-08-16 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 1187 of the VPS13B protein (p.Val1187Ile). This variant is present in population databases (rs151247807, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with VPS13B-related conditions. ClinVar contains an entry for this variant (Variation ID: 597994). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Not Available"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001042782 | SCV002082518 | uncertain significance | Cohen syndrome | 2019-11-11 | no assertion criteria provided | clinical testing |